BIOPHEN™ DiXaI — Two-Stage Anti-Xa for Direct Xa Inhibitors
Processing...

BIOPHEN™ DiXaI — Two-Stage Anti-Xa for Direct Xa Inhibitors

Code: A221030-RUO
Manufacturer’s Part Number: 221030-RUO
Product size: Kit
Clearance: RUO

Price: $440.00

Qty

Product Description

For Research Use Only. Not for Use in Diagnostic Procedures.

Two-stage chromogenic anti-Xa method specifically designed for the quantitative measurement of direct Factor Xa inhibitors (DiXaIs) in citrated human plasma: Rivaroxaban (Xarelto®), Apixaban (Eliquis®), and Edoxaban (Lixiana®).

Important: This method is NOT suitable for indirect inhibitors such as heparins or Fondaparinux. Use BIOPHEN™ Heparin LRT (ref. 221011/221013/221015) for those analytes.

  • Two-stage method provides high DiXaI specificity not achievable with one-stage anti-Xa assays
  • Dedicated calibrator and control plasmas for each drug (Rivaroxaban, Apixaban, Edoxaban)
  • Use with Tris-NaCl-EDTA buffer (ref. AR032K) to reduce heparin interference in mixed samples
  • CE-IVD

Product Characteristics

  • Total Assay Time: < 10 min
  • Dynamic Range:
      Standard Range (Rivaroxaban): 0 to 500 ng/mL
      Low Range (Rivaroxaban): 0 to 100 ng/mL
      Standard Range (Apixaban): 0 to 600 ng/mL
      Low Range (Apixaban): 0 to 120 ng/mL
  • Number of Tests (Manual Method): 3 x 10 Tests

Product Components

  • R1: 3 x 2.5 mL purified human FXa, lyophilized.
  • R2: 3 x 2.5 mL FXa chromogenic substrate, lyophilized.
  • R3: 4 x 20 mL Tris-NaCl-EDTA-PEG Buffer, pH 7.85. Ready to use.

Product Applications

For the measurement of Rivaroxaban, Apixaban, and other direct Factor Xa inhibitors in research applications.

Instructions For Use

Material Safety Data Sheet (MSDS)

Data Sheet/Technical Data

Other Documents